DNAtriX Company

DNAtriX is a biotechnology company developing an oncolytic virus platform for treating malignant glioma.

Total Funding: $57 084 013
Headquarters: Houston, Texas, United States
Estimated Revenue: $500M to $1B
Last Funding Type: Venture - Series Unknown
Last Funding Date: 2018-09-12
Founded Date: 2005-01-01
Industry: Women Cancer Treatment